Literature DB >> 20027366

Tenoten in the therapy of anxious disturbances in patients with essential hypertension and coronary heart disease.

N P Vanchakova1, A P Popov.   

Abstract

The study demonstrated high anxiolytic activity of tenoten, which was not inferior to the anxiolytic effect of grandaxin. The positive changes persisted after termination of treatment in the tenoten group (but not in grandaxin group). Tenoten can be recommended for the treatment of patients with cardiovascular diseases associated with neurotic disturbances.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20027366     DOI: 10.1007/s10517-009-0682-0

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Dose-Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light-Dark Test in Mice.

Authors:  Elena V Kardash; Irina A Ertuzun; Gul'nara R Khakimova; Andrey N Kolyadin; Sergey A Tarasov; Stéphanie Wagner; Emile Andriambeloson; Vladimir T Ivashkin; Oleg I Epstein
Journal:  Dose Response       Date:  2018-06-26       Impact factor: 2.658

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.